Skip to main content
Top
Published in: Virology Journal 1/2009

Open Access 01-12-2009 | Research

The interaction of hepatitis A virus (HAV) with soluble forms of its cellular receptor 1 (HAVCR1) share the physiological requirements of infectivity in cell culture

Authors: Erica Silberstein, Krishnamurthy Konduru, Gerardo G Kaplan

Published in: Virology Journal | Issue 1/2009

Login to get access

Abstract

Background

Hepatitis A virus (HAV), an atypical Picornaviridae that causes acute hepatitis in humans, usurps the HAV cellular receptor 1 (HAVCR1) to infect cells. HAVCR1 is a class 1 integral membrane glycoprotein that contains two extracellular domains: a virus-binding immunoglobulin-like (IgV) domain and a mucin-like domain that extends the IgV from the cell membrane. Soluble forms of HAVCR1 bind, alter, and neutralize cell culture-adapted HAV, which is attenuated for humans. However, the requirements of the HAV-HAVCR1 interaction have not been fully characterized, and it has not been determined whether HAVCR1 also serves as a receptor for wild-type (wt) HAV. Here, we used HAV soluble receptor neutralization and alteration assays to study the requirements of the HAV-HAVCR1 interaction and to determine whether HAVCR1 is also a receptor for wt HAV.

Results

Treatment of HAV with a soluble form of HAVCR1 that contained the IgV and two-thirds of the mucin domain fused to the Fc fragment of human IgG1 (D1 muc-Fc), altered particles at 37°C but left a residual level of unaltered particles at 4°C. The kinetics of neutralization of HAV by D1 muc-Fc was faster at 37°C than at 4°C. Alteration of HAV particles by D1 muc-Fc required Ca, which could not be replaced by Li, Na, Mg, Mn, or Zn. Neutralization of HAV by D1 muc-Fc occurred at pH 5 to 8 but was more efficient at pH 6 to 7. D1 muc-Fc neutralized wt HAV as determined by a cell culture system that allows the growth of wt HAV.

Conclusion

The interaction of HAV with soluble forms of HAVCR1 shares the temperature, Ca, and pH requirements for infectivity in cell culture and therefore mimics the cell entry process of HAV. Since soluble forms of HAVCR1 also neutralized wt HAV, this receptor may play a significant role in pathogenesis of HAV.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hollinger FB, Emerson SU: Hepatitis A virus. In Fields Virology. Volume 1. Fourth edition. Edited by: Knipe DM, Howley PM. Philadelphia: Lippincott Williams & Wilkins; 2008:911-948. Hollinger FB, Emerson SU: Hepatitis A virus. In Fields Virology. Volume 1. Fourth edition. Edited by: Knipe DM, Howley PM. Philadelphia: Lippincott Williams & Wilkins; 2008:911-948.
2.
go back to reference Probst C, Jecht M, Gauss-Muller V: Intrinsic signals for the assembly of hepatits A virus particles. J Biol Chem 1999, 274: 4527-4531. 10.1074/jbc.274.8.4527CrossRefPubMed Probst C, Jecht M, Gauss-Muller V: Intrinsic signals for the assembly of hepatits A virus particles. J Biol Chem 1999, 274: 4527-4531. 10.1074/jbc.274.8.4527CrossRefPubMed
3.
go back to reference Kaplan G, Totsuka A, Thompson P, Akatsuka T, Moritsugu Y, Feinstone SM: Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. Embo J 1996, 15: 4282-4296.PubMedCentralPubMed Kaplan G, Totsuka A, Thompson P, Akatsuka T, Moritsugu Y, Feinstone SM: Identification of a surface glycoprotein on African green monkey kidney cells as a receptor for hepatitis A virus. Embo J 1996, 15: 4282-4296.PubMedCentralPubMed
4.
go back to reference Feigelstock D, Thompson P, Mattoo P, Zhang Y, Kaplan GG: The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J Virol 1998, 72: 6621-6628.PubMedCentralPubMed Feigelstock D, Thompson P, Mattoo P, Zhang Y, Kaplan GG: The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J Virol 1998, 72: 6621-6628.PubMedCentralPubMed
5.
go back to reference McIntire JJ, Umetsu SE, Macaubas C, Hoyte EG, Cinnioglu C, Cavalli-Sforza LL, Barsh GS, Hallmayer JF, Underhill PA, Risch NJ, et al.: Immunology: hepatitis A virus link to atopic disease. Nature 2003, 425: 576. 10.1038/425576aCrossRefPubMed McIntire JJ, Umetsu SE, Macaubas C, Hoyte EG, Cinnioglu C, Cavalli-Sforza LL, Barsh GS, Hallmayer JF, Underhill PA, Risch NJ, et al.: Immunology: hepatitis A virus link to atopic disease. Nature 2003, 425: 576. 10.1038/425576aCrossRefPubMed
6.
go back to reference McIntire JJ, Umetsu DT, DeKruyff RH: TIM-1, a novel allergy and asthma susceptibility gene. Springer Semin Immunopathol 2004, 25: 335-348. 10.1007/s00281-003-0141-3CrossRefPubMed McIntire JJ, Umetsu DT, DeKruyff RH: TIM-1, a novel allergy and asthma susceptibility gene. Springer Semin Immunopathol 2004, 25: 335-348. 10.1007/s00281-003-0141-3CrossRefPubMed
7.
go back to reference Matricardi PM, Rosmini F, Ferrigno L, Nisini R, Rapicetta M, Chionne P, Stroffolini T, Pasquini P, D'Amelio R: Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis a virus. BMJ 1997, 314: 999-1003.PubMedCentralCrossRefPubMed Matricardi PM, Rosmini F, Ferrigno L, Nisini R, Rapicetta M, Chionne P, Stroffolini T, Pasquini P, D'Amelio R: Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis a virus. BMJ 1997, 314: 999-1003.PubMedCentralCrossRefPubMed
8.
go back to reference Matricardi PM, Rosmini F, Panetta V, Ferrigno L, Bonini S: Hay fever and asthma in relation to markers of infection in the United States. J Allergy Clin Immunol 2002, 110: 381-387. 10.1067/mai.2002.126658CrossRefPubMed Matricardi PM, Rosmini F, Panetta V, Ferrigno L, Bonini S: Hay fever and asthma in relation to markers of infection in the United States. J Allergy Clin Immunol 2002, 110: 381-387. 10.1067/mai.2002.126658CrossRefPubMed
9.
go back to reference Thompson P, Lu J, Kaplan GG: The Cys-rich region of hepatitis A virus cellular receptor 1 is required for binding of hepatitis A virus and protective monoclonal antibody 190/4. J Virol 1998, 72: 3751-3761.PubMedCentralPubMed Thompson P, Lu J, Kaplan GG: The Cys-rich region of hepatitis A virus cellular receptor 1 is required for binding of hepatitis A virus and protective monoclonal antibody 190/4. J Virol 1998, 72: 3751-3761.PubMedCentralPubMed
10.
go back to reference Silberstein E, Xing L, Beek W, Lu J, Cheng H, Kaplan GG: Alteration of Hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobulin- and mucin-like regions. Journal of Virology 2003, 77: 8765-8774. 10.1128/JVI.77.16.8765-8774.2003PubMedCentralCrossRefPubMed Silberstein E, Xing L, Beek W, Lu J, Cheng H, Kaplan GG: Alteration of Hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobulin- and mucin-like regions. Journal of Virology 2003, 77: 8765-8774. 10.1128/JVI.77.16.8765-8774.2003PubMedCentralCrossRefPubMed
11.
go back to reference Bishop NE: Effect of low pH on the hepatitis A virus maturation cleavage. Acta virologica 1999, 43: 291-296.PubMed Bishop NE: Effect of low pH on the hepatitis A virus maturation cleavage. Acta virologica 1999, 43: 291-296.PubMed
12.
go back to reference Bishop NE, Anderson DA: Early interactions of hepatitis A virus with cultured cells: viral elution and the effect of pH and calcium ions. Arch Virol 1997, 142: 2161-2178. 10.1007/s007050050233CrossRefPubMed Bishop NE, Anderson DA: Early interactions of hepatitis A virus with cultured cells: viral elution and the effect of pH and calcium ions. Arch Virol 1997, 142: 2161-2178. 10.1007/s007050050233CrossRefPubMed
13.
go back to reference Silberstein E, Xing L, Beek W, Lu J, Cheng H, Kaplan GG: Alteration of hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobin-and mucin-like regions. J Virol 2003, 77: 8765-8774. 10.1128/JVI.77.16.8765-8774.2003PubMedCentralCrossRefPubMed Silberstein E, Xing L, Beek W, Lu J, Cheng H, Kaplan GG: Alteration of hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobin-and mucin-like regions. J Virol 2003, 77: 8765-8774. 10.1128/JVI.77.16.8765-8774.2003PubMedCentralCrossRefPubMed
14.
go back to reference Stapleton JT, Frederick J, Meyer B: Hepatitis A virus attachment to cultured cell lines. J Infect Dis 1991, 164: 1098-1103.CrossRefPubMed Stapleton JT, Frederick J, Meyer B: Hepatitis A virus attachment to cultured cell lines. J Infect Dis 1991, 164: 1098-1103.CrossRefPubMed
15.
go back to reference Zajac AJ, Amphlett EM, Rowlands DJ, Sangar DV: Parameters influencing the attachment of hepatitis A virus to a variety continuous cell lines. J Virol 1991, 72: 1667-1675. 10.1099/0022-1317-72-7-1667CrossRef Zajac AJ, Amphlett EM, Rowlands DJ, Sangar DV: Parameters influencing the attachment of hepatitis A virus to a variety continuous cell lines. J Virol 1991, 72: 1667-1675. 10.1099/0022-1317-72-7-1667CrossRef
16.
go back to reference Silberstein E, Dveksler G, Kaplan GG: Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1. J Virol 2001, 75: 717-725. 10.1128/JVI.75.2.717-725.2001PubMedCentralCrossRefPubMed Silberstein E, Dveksler G, Kaplan GG: Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1. J Virol 2001, 75: 717-725. 10.1128/JVI.75.2.717-725.2001PubMedCentralCrossRefPubMed
17.
go back to reference Silberstein E, Xing L, Beek W, Lu J, Cheng H, Kaplan GG: Alteration of Hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobulin- and mucin-like regions. J Virol 2003, 77: 8765-8774. 10.1128/JVI.77.16.8765-8774.2003PubMedCentralCrossRefPubMed Silberstein E, Xing L, Beek W, Lu J, Cheng H, Kaplan GG: Alteration of Hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobulin- and mucin-like regions. J Virol 2003, 77: 8765-8774. 10.1128/JVI.77.16.8765-8774.2003PubMedCentralCrossRefPubMed
18.
19.
go back to reference Konduru K, Virata-Theimer ML, Yu MY, Kaplan GG: A simple and rapid Hepatitis A Virus (HAV) titration assay based on antibiotic resistance of infected cells: evaluation of the HAV neutralization potency of human immune globulin preparations. Virol J 2008, 5: 155. 10.1186/1743-422X-5-155PubMedCentralCrossRefPubMed Konduru K, Virata-Theimer ML, Yu MY, Kaplan GG: A simple and rapid Hepatitis A Virus (HAV) titration assay based on antibiotic resistance of infected cells: evaluation of the HAV neutralization potency of human immune globulin preparations. Virol J 2008, 5: 155. 10.1186/1743-422X-5-155PubMedCentralCrossRefPubMed
20.
go back to reference Bishop NE, Anderson DA: Early interactions of hepatitis A virus with cultured cells: viral elution and the effect of pH and calcium ions. Arch Virol 1997, 142: 2161-2178. 10.1007/s007050050233CrossRefPubMed Bishop NE, Anderson DA: Early interactions of hepatitis A virus with cultured cells: viral elution and the effect of pH and calcium ions. Arch Virol 1997, 142: 2161-2178. 10.1007/s007050050233CrossRefPubMed
21.
go back to reference Stapleton JT, Frederick J, Meyer B: Hepatitis A virus attachment to cultured cell lines. J Infect Dis 1991, 164: 1098-1103.CrossRefPubMed Stapleton JT, Frederick J, Meyer B: Hepatitis A virus attachment to cultured cell lines. J Infect Dis 1991, 164: 1098-1103.CrossRefPubMed
22.
go back to reference Zajac AJ, Amphett EM, Rowlands DJ, Sangar DV: Parameters influencing the attchment of hepatitis A virus to a variety of continuous cell lines. Journal of General Virology 1991, 72: 1667-1675. 10.1099/0022-1317-72-7-1667CrossRefPubMed Zajac AJ, Amphett EM, Rowlands DJ, Sangar DV: Parameters influencing the attchment of hepatitis A virus to a variety of continuous cell lines. Journal of General Virology 1991, 72: 1667-1675. 10.1099/0022-1317-72-7-1667CrossRefPubMed
23.
go back to reference Dimmok NJ: Mechanisms of neutralization of animal viruses. J Gen Virol 1984, 65: 1015-1022. 10.1099/0022-1317-65-6-1015CrossRef Dimmok NJ: Mechanisms of neutralization of animal viruses. J Gen Virol 1984, 65: 1015-1022. 10.1099/0022-1317-65-6-1015CrossRef
24.
go back to reference Mandel B: Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction. Virology 1976, 69: 500-510. 10.1016/0042-6822(76)90480-3CrossRefPubMed Mandel B: Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction. Virology 1976, 69: 500-510. 10.1016/0042-6822(76)90480-3CrossRefPubMed
25.
go back to reference Ruiz MC, Cohen J, Michelangeli F: Role of Ca2+in the replication and pathogenesis of rotavirus and other viral infections. Cell Calcium 2000, 28: 137-149. 10.1054/ceca.2000.0142CrossRefPubMed Ruiz MC, Cohen J, Michelangeli F: Role of Ca2+in the replication and pathogenesis of rotavirus and other viral infections. Cell Calcium 2000, 28: 137-149. 10.1054/ceca.2000.0142CrossRefPubMed
26.
go back to reference Sanchez G, Aragones L, Costafreda MI, Ribes E, Bosch A, Pinto RM: Capsid region involved in hepatitis A virus binding to glycophorin A of the erythrocyte membrane. J Virol 2004, 78: 9807-9813. 10.1128/JVI.78.18.9807-9813.2004PubMedCentralCrossRefPubMed Sanchez G, Aragones L, Costafreda MI, Ribes E, Bosch A, Pinto RM: Capsid region involved in hepatitis A virus binding to glycophorin A of the erythrocyte membrane. J Virol 2004, 78: 9807-9813. 10.1128/JVI.78.18.9807-9813.2004PubMedCentralCrossRefPubMed
27.
go back to reference Totsuka A, Moritsugu Y: Hepatitis A vaccine development in Japan. In Viral hepatitis and liver disease. Edited by: Nishioka KHS, Mishiro S, Oda T. Tokyo, Japan.: Springer Verlag; 1994:509-513.CrossRef Totsuka A, Moritsugu Y: Hepatitis A vaccine development in Japan. In Viral hepatitis and liver disease. Edited by: Nishioka KHS, Mishiro S, Oda T. Tokyo, Japan.: Springer Verlag; 1994:509-513.CrossRef
28.
go back to reference Cohen JI, Rosenblum B, Feinstone SM, Ticehurst J, Purcell RH: Attenuation and cell culture adaptation of hepatitis A virus (HAV): agenetic analysis with HAV cDNA. J Virol 1989, 63: 5364-5370.PubMedCentralPubMed Cohen JI, Rosenblum B, Feinstone SM, Ticehurst J, Purcell RH: Attenuation and cell culture adaptation of hepatitis A virus (HAV): agenetic analysis with HAV cDNA. J Virol 1989, 63: 5364-5370.PubMedCentralPubMed
29.
go back to reference Cromeans T, Sobsey MD, Fields HA: Development of a plaque assay for a cytopathic, rapidly replicating isolate of hepatitis A virus. J Med Virol 1987, 22: 45-56. 10.1002/jmv.1890220107CrossRefPubMed Cromeans T, Sobsey MD, Fields HA: Development of a plaque assay for a cytopathic, rapidly replicating isolate of hepatitis A virus. J Med Virol 1987, 22: 45-56. 10.1002/jmv.1890220107CrossRefPubMed
30.
go back to reference Reed LJ, Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg 1938, 27: 493-497. Reed LJ, Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg 1938, 27: 493-497.
31.
go back to reference Marissen WE, Kramer RA, Rice A, Weldon WC, Niezgoda M, Faber M, Slootstra JW, Meloen RH, Clijsters-van der Horst M, Visser TJ, et al.: Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis. J Virol 2005, 79: 4672-4678. 10.1128/JVI.79.8.4672-4678.2005PubMedCentralCrossRefPubMed Marissen WE, Kramer RA, Rice A, Weldon WC, Niezgoda M, Faber M, Slootstra JW, Meloen RH, Clijsters-van der Horst M, Visser TJ, et al.: Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis. J Virol 2005, 79: 4672-4678. 10.1128/JVI.79.8.4672-4678.2005PubMedCentralCrossRefPubMed
32.
go back to reference Kaplan G, Peters D, Racaniello VR: Poliovirus mutants resistant to neutralization with soluble cell receptors. Science 1990, 250: 1596-1609. 10.1126/science.2177226CrossRefPubMed Kaplan G, Peters D, Racaniello VR: Poliovirus mutants resistant to neutralization with soluble cell receptors. Science 1990, 250: 1596-1609. 10.1126/science.2177226CrossRefPubMed
Metadata
Title
The interaction of hepatitis A virus (HAV) with soluble forms of its cellular receptor 1 (HAVCR1) share the physiological requirements of infectivity in cell culture
Authors
Erica Silberstein
Krishnamurthy Konduru
Gerardo G Kaplan
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2009
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-6-175

Other articles of this Issue 1/2009

Virology Journal 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine